SFRP1 and chronic kidney disease: Expression of other Wnt inhibitors, namely, SFRP-1, SFRP-2, and SFRP-4, has also been reported in the calcified vessels of a CKD rat model [132], supporting the idea that the vasculature could be a contributor to serum Wnt inhibitors levels.